CLINAM 2018

The Regulatory Authorities’ Voice 2018 - Switzerland

Panel: The Regulatory Authorities’ Voice 2018

Opening Address from the European Foundation for Clinical Nanomedicine

The Regulatory Authorities’ Voice 2018 - USA

Panel: EUNCL European Nanomedicine Characterization Laboratory – Lessons learned

Introduction

Closing Words

The Various Faces of Precision Medicine

The CLINAM Network for Advancing Nanomedicine

The Regulatory Authorities’ Voice 2018 - Canada

The Zebrafish: A Preclinical Screening Model for the Optimization of Nanomedicine Formulations

Small Speeches on Submitted Posters and on University Village Posters 2018

Panel: Nanomedicine and Precision Medicine Context in the Future

Characterization Challenges for Non‐Biological Complex Drugs and Their Follow‐on Versions

The European NanoAthero Project: From the Design to the Clinical Trials

Protein‐sized and Ultrabright Dye‐loaded Polymer Nanoparticles for Intracellular Imaging

Personalization by Precise Knowledge and Precise Therapies, Enabled by Nanomedicine

Engineering Innate and Adaptive Immunity with Polymeric Materials

Targeting of Antigen Presenting Cells for Tumor Immunotherapy

Introduction

CART Manufacturing

Panel: Global Clinical Experience with Non‐Biological Complex Drugs (NBCDs) and their Follow‐on...

Redefining Therapeutic Agents Bioavailability by Transient Nanoparticle Liver Saturation

Opening Address from the European Foundation for Clinical Nanomedicine